ConductScience.org, home

Paper326378

Evidence on screening for breast cancer from a randomized trial.

Shapiro S. Cancer, 1977. Cited by 486 papers, by iCite.

Cite this record

ConductScience Library. Evidence on screening for breast cancer from a randomized trial. Papers, record 326378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326378

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evidence on screening for breast cancer from a randomized trial.
PubMed
Journal
Cancer
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
486
iCite
Relative citation ratio, by iCite
18.9
iCite
Revised in PubMed
2026-01-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shapiro SS

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Adult
Age Factors
Clinical Trials as Topic
Female
Humans
Mammography
Mass Screening
Middle Aged
New York
Risk

Source PubMed

Download CSV of topics

Cited by108

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 486 citations.

PMIDTitleJournalYearIn PapersSource
40876822Extending the Age Range in Mammography Screening: A Benefit-Risk Assessment from a Radiation Protection Perspective.Rofo2026https://conductscience.org/library/papers/40876822PubMed
40468448Matrix stiffness-induced IKBKE and MAPK8 signaling drives a phenotypic switch from DCIS to invasive breast cancer.Cell Commun Signal2025https://conductscience.org/library/papers/40468448PubMed
38752988Disparities in Mammography Screening: Analyzing Barriers to Access Using Individual Patient Perspectives and the Health Belief Model.Cancer Control2024https://conductscience.org/library/papers/38752988PubMed
37878149Breast cancer outcomes based on method of detection in community-based breast cancer registry.Breast Cancer Res Treat2024https://conductscience.org/library/papers/37878149PubMed
36453850Key concepts for informed health choices. 2.1: comparisons of treatments should be fair.J R Soc Med2023https://conductscience.org/library/papers/36453850PubMed
36005183Misinformation and Facts about Breast Cancer Screening.Curr Oncol2022https://conductscience.org/library/papers/36005183PubMed
34421215Mammograms and Mortality: How Has the Evidence Evolved?J Econ Perspect2021https://conductscience.org/library/papers/34421215PubMed
34199804Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I).J Pers Med2021https://conductscience.org/library/papers/34199804PubMed
30179570Limitations in the Effect of Screening on Breast Cancer Mortality.J Clin Oncol2018https://conductscience.org/library/papers/30179570PubMed
29402176Estimating the frequency of indolent breast cancer in screening trials.Stat Methods Med Res2019https://conductscience.org/library/papers/29402176PubMed
28591356Early detection of breast cancer in Brazil: data from the National Health Survey, 2013.Rev Saude Publica2017https://conductscience.org/library/papers/28591356PubMed
28493302Instrumental variables estimation of exposure effects on a time-to-event endpoint using structural cumulative survival models.Biometrics2017https://conductscience.org/library/papers/28493302PubMed
27100174Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening.PLoS One2016https://conductscience.org/library/papers/27100174PubMed
25302030Impact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age.Curr Oncol2014https://conductscience.org/library/papers/25302030PubMed
25114845Pathogenesis, prevention, diagnosis and treatment of breast cancer.World J Clin Oncol2014https://conductscience.org/library/papers/25114845PubMed
24536051Arguments against mammography screening continue to be based on faulty science.Oncologist2014https://conductscience.org/library/papers/24536051PubMed
24519768Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.BMJ2014https://conductscience.org/library/papers/24519768PubMed
24495817Measuring the mortality impact of breast cancer screening.Can J Public Health2013https://conductscience.org/library/papers/24495817PubMed
24218000The global challenge of reducing breast cancer mortality.Oncologist2013https://conductscience.org/library/papers/24218000PubMed
24212617Rational and irrational issues in breast cancer screening.Cancers (Basel)2011https://conductscience.org/library/papers/24212617PubMed

See all 108 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/326378

GET https://conductscience.org/api/papers/v1/326378/cited_by?page=2